infection of certain cell types by hiv results in formation of syncytia. this process can be blocked by antibodies or compounds that prevent interaction of viral envelope protein with host cell receptors. here the authors describe an automated imaging-based assay for inhibitors of cell-cell fusion mediated by interaction of hiv gp120 with cXcr4 coreceptor. the assay quantifies syncytia formation between U87MG astrocytoma cells constitutively expressing cD4/cXcr4 and morphologically distinct Jurkat t lymphoma cells inducibly expressing hiv env. each cell type was differentially labeled with vital dyes. Fusion was quantified by measuring size, shape, and color of Jurkat cells and Jurkat-harboring cell syncytia. Doseresponse experiments with reference inhibitors aMD 3100 and Krh-1636 yielded potencies consistent with those obtained using standard antiviral assays. this assay complements virus-based infectivity assays for identification of inhibitors of membrane fusion events triggered by interaction of hiv gp120 with host cXcr4. (Journal of Biomolecular Screening 2011;16:668-675) 
IntroductIon

E
ssential steps in hiv entry involve interaction of the viral gp120 envelope glycoprotein with host cell cD4 plus one of two coreceptors, ccr5 or cXcr4. hiv coreceptors belong to the G-protein-coupled receptor (Gpcr) family, which normally function in chemokine signaling: ccr5 is triggered by rantes and Mip-1β, whereas cXcr4 is triggered by sDF-1. the dependency of hiv for either ccr5 or cXcr4 defines the tropism of the virus for specific cells of the lymphoid or myeloid lineage. 1 Drug discovery efforts targeting either coreceptor recently led to the development of several specifically ccr5-or cXcr4-binding agents (for recent review, see Qian et al. 2 ). Maraviroc blocking ccr5 received regulatory approval in 2007. 3 Development of cXcr4-specific inhibitors of hiv entry has proven more challenging than ccr5 inhibitors. Blockade of cXcr4 signaling affects numerous physiological processes, and although several agents targeting cXcr4 entered clinical trials, none have been successfully developed for treatment of hiv. 4 virus-based assays have been used to study multiple steps of the complex hiv entry process. 5 surrogate assays for various steps have been employed to screen small-molecule libraries for inhibitors of ccr5-or cXcr4-mediated viral entry. For cXcr4-tropic hiv, these include sDF-1 signaling assays and assays that measure fusion of cells expressing the cXcr4 coreceptor and cD4 primary receptor with cells expressing the complete hiv env gene encoding gp120 and gp41. such cellcell fusion assays often rely on expression of a reporter gene provided by one cell partner in response to an activator provided by the other partner. 6 resonance energy transfer reporters also have been shown to be sensitive and specific for quantification of fusion events (for a review of cell-cell fusion assays, see shinn-thomas et al. 7 ). recently, flow cytometry and high-content analysis protocols have been developed to measure syncytia formation between distinctly labeled cell populations. [8] [9] [10] here we describe the application of a similar labeling technique to cXcr4/hivenv-mediated cell fusion. We present a high-content/highthroughput assay for quantification of cXcr4-gp120-dependent cell fusion.
MAterIALS And MethodS
Cell lines and reference compounds
Jurkat-hXBc2 cells were obtained through the national institutes of health (nih) aiDs research and reference reagent program, Division of aiDs, national institute of allergy and infectious Diseases (from Dr. Joseph sodroski, catalog number 3952). Jurkat-hXBc2 cells contain the env gene (gp160/gp41) from the hiv-1 hXBc2 strain controlled by an inducible tetracycline-dependent cytomegalovirus (cMv) promoter. cells were maintained as previously described. 11 For induction of hXBc2 env expression, tetracycline was withdrawn 5 days prior to use of Jurkat hXBc2 in the fusion assay.
cXcr4 expressing U87MG-cD4 (see Björndal et al. 1 and references therein) were kindly provided by Dr. Dan littman (skirball institute of Biomolecular Medicine, new york, ny) and maintained in Dulbecco's modified eagle's medium (DMeM) supplemented with 10% fetal bovine serum (FBs), 100 iU/ml penicillin-streptomycin, 10 mM hepes, 4 mM l-glutamine, 1× nonessential amino acids (neaas), 1 g/ml sodium bicarbonate, 250 µg/ml G418, and 1 µg/ml puromycin.
aMD 3100 and Krh-1636 compound were synthesized at schering-plough research institute (Kenilworth, nJ). all compounds were dissolved in 100% DMso.
General assay procedure in 96-or 384-well plates
all cell plating steps were carried out on a Biomek FX laboratory automation Workstation (Beckman coulter, Brea, ca).
twenty-four hours prior to the assay, U87MG-cXcr4 were harvested and stained with 10 µM celltracker orange cMra (Molecular probes, invitrogen corp., eugene, or) at a density of 1 × 10 6 cells for 30 min at 37 °c. cells were washed in phosphate-buffered saline (pBs) and resuspended in growth medium. assay medium was predispensed into uncoated multiwell plates (0.72-mm thick low glass bottom; Matrical, spokane, Wa) to cover the surface. subsequently, U87MG-cXcr4 cell suspension was added to provide 12 000 (96-well) or 3000 (384-well) cells per well. plates were spun briefly at 200 g to ensure even cell distribution and were incubated overnight at 37 °c.
on the assay day, Jurkat-hXBc2 were labeled with 1 µM celltracker Green cMFDa (5-chloromethylfluorescein diacetate; Molecular probes) at a density of 1 × 10 6 cells for 30 min at 37 °c, washed in pBs, and resuspended in assay medium. then, 15 000 Jurkat-hXBc2 cells per well were dispensed into 96-well polypropylene v-bottom cell culture plates (thermo Fisher, rochester, ny).
Both cell types were preincubated with serial compound dilutions for 1 h at 37 °c. compounds were first serially diluted in 100% DMso at 200× concentration (precision 2000 Microplate pipetting system; Biotek, Winooski, vt) in 96-well polypropylene v-bottom plates. intermediate dilution plates containing 5% DMso in serum-free medium were used prior to transfer onto U87MG-cXcr4 and JurkathXBc2 cells to achieve a final DMso concentration in the assay of 0.5%. pretreated Jurkat-hXBc2 cells were then transferred onto corresponding pretreated U87MG-cXcr4. eight wells per 96-well plate or 32 wells per 384-well plate containing U87MG-cXcr4 did not receive Jurkat-hXBc2 cells. these wells were used as analysis parameter standards (aps) for later image analysis by adding prefixed untreated Jurkat-hXBc2.
plates were briefly centrifuged at 800 rpm and returned to the incubator for 4 h. the assay was stopped by addition of 16% paraformaldehyde (pFa; alfa aesar, Johnson Matthew company, Ward hill, Ma) to achieve a final concentration of 4%. assay plates could be stored at 4 °c for up to 4 weeks without affecting assay results.
Image acquisition and analysis
images were acquired on a lsM 510 Meta (carl Zeiss Microimaging, thornwood, ny) equipped with an automated stage using the aiM Multitime macro in Multitrack mode (ec plan neofluor 10×/0.3 na objective). celltracker Green was excited with a 488-nm laser at a 5% laser transmission; emitted light was collected through a Bp 505-to 530-nm filter. celltracker orange was excited with a 543-nm laser at 25% laser transmission; emitted light was collected through an lp 560-nm filter. prior to each image acquisition, an autofocus step was executed. lsM images were batch-converted to zvi format by axiovision (carl Zeiss Microimaging) and distributed into folders representing layouts of multiwell plates by Moover software (DaX technologies corp, Matawan, nJ).
image analysis was performed using the physiology analyst of the assayBuilder hca Module of the carl Zeiss axiovision software 12 and is described in the main result section and in more detail in Supplemental Figure S1A-d.
Statistical analysis
the numbers of nonfused Jurkat-hXBc2 (free objects plus attached objects) per reaction were counted. numbers of fused cells were calculated by dividing the total area of syncytia (multinucleated large objects generated by fusion of multiple cells) per reaction by the size-mean of nonfused Jurkat-hXBc2 (see below for details). Fractions were calculated according to the following equations: Fractions of fused Jurkat cells as a function of compound concentration were fitted to a four-parameter curve-fit model in Graphpad prism software (Graphpad software, la Jolla, ca) to calculate ec 50 and 95% confidence intervals.
the Z′ factor was calculated from independent 384-well assay plates according to the procedure described recently 13 using the following equation:
reSuLtS And dIScuSSIon
Basic assay principle the assay described here quantifies the fusion of hiv envelope expressing Jurkat-hXBc2 with U87MG cells expressing cD4 and cXcr4. the two cell types are morphologically distinct and were differentially labeled with red and green fluorescent celltracker dyes. red adherent U87MG-cXcr4 cells were combined with green small suspension Jurkat-hXBc2 (Fig. 1A) . cell fusion was observed as early as 3 h after combination of the Jurkat-hXBc2 cells with U87MG-cXcr4 cells. low-magnification images (10× objective) were acquired and subjected to image analysis.
the image analysis sequence consists of identifying objects representing Jurkat cells and Jurkat-derived fusion objects according to the celltracker green signal. all identified green objects were grouped according to their morphology and red intensity into the following three categories: free (Jurkat-hXBc2 not associated with U87MG-cXcr4), attached (Jurkat-hXBc2 in close proximity to U87MG-cXcr4 but not yet internalized), and fused (JurkathXBc2 fully internalized by U87MG-cXcr4). For each green object, size, shape (p2a, ratio of perimeter of an object squared to 4π multiplied by object area), and red intensity were determined. the automated image analysis sequence for each acquisition run was focused on morphologically uniform Jurkat cells in analysis parameter standard wells (for details, see Supplemental Figure S1A ). this provided a reproducible and robust way for reliable identification and segmentation of nonfused cells. transfer of red fluorescence from U87MG-cXcr4 to Jurkat cells combined with the change of cell shape after fusion provided key criteria for the identification of fusion events.
as shown in Figure 1B , fusion of Jurkat-hXBc2 to U87MG-cXcr4 generates large, irregularly shaped green objects ( 1B, middle images) representing syncytia. such syncytia become predominant over unfused cells, which are small and round, as depicted in aps (pFa fixation before cell combination) or aMD 3100-treated reactions (Fig. 1B, top and Fig. 1c, size histogram) .
analysis parameter standards or aMD 3100 reactions yielded predominantly round green objects (cells) reflected by a narrow p2a peak with a mean of 1.2 (p2a of 1 would reflect perfect roundness). in DMso reactions, a wider peak indicated the occurrence of more irregularly shaped objects (syncytia; Fig. 1c, shape histogram) .
Green cells in analysis parameter standard wells showed only background red intensity (e.g., here <900 relative fluorescence units [rFUs] ). in contrast, green cells that fused to adherent reddyed U87MG-cXcr4 acquired significantly higher red fluorescence, reflected by a narrow peak of high red intensity cells shown in a representative intensity histogram in Figure 1c .
We analyzed the statistical distribution of the three parameters described above in at least 10 analysis parameter standards and DMso control reactions for each acquisition run, and the means and standard deviations (sD) per control were automatically calculated. thresholds for size, shape, and red intensity were set based on the statistical distributions; green objects were categorized by a two-step algorithm as either nonfused or fused (depicted in Fig. 2A) . First, green objects falling within 2 standard deviations (sD) of the shape mean and within 2 sD of the size-mean of analysis parameter standard wells were preliminarily categorized as "nonfused" (Fig. 2A) . second, all nonfused objects with red fluorescence intensities within 3 sD of the intensity mean of the analysis parameter standards were categorized as "free." nonfused objects bearing red fluorescence intensities above intensity mean plus 3 sD of analysis parameter standards but below the intensity mean of DMso control reactions were confirmed as "attached." these thresholds were automatically applied to every image acquired during one image acquisition run, and the grouping of objects was performed accordingly by the assayBuilder software.
all green objects harboring a red fluorescence intensity greater than or equal to the mean of DMso reactions were considered fused independent of their size and shape. these fusion objects (i.e., syncytia) varied in size and also contained variable numbers of Jurkat cells, both of which contributed to variation in quantification of the number of Jurkat cells categorized as fused. it is important to note that object identification and segmentation settings in the image analysis sequence were defined based on analysis parameter standard wells to allow identification of single, round Jurkat cells with high accuracy. the same settings were subsequently applied to all images of one acquisition run. however, this approach affected object identification and segmentation in reactions with cell fusion events, yielding counts of valid objects that did not correspond to the number of cells used in the reaction. We observed that the totals of valid Jurkat objects could be either greater than or less than the number of input cells. We noted that under-and overestimation of cell counts could occur because of insufficient segmentation of fusion objects (syncytia), leading to smaller Jurkat counts, or exaggerated segmentation, especially in large fusion objects, leading to larger Jurkat counts.
to correct for the effect of variation in segmentation of fusion objects, we calculated the sum of the area of all fusion objects in each image and divided it by the mean area of JurkathXBc2 cells from the analysis parameter standard wells. the calculated number of fused Jurkat cells was then divided by the total number of Jurkat objects in the well (free, attached, and fused) to calculate fraction fused. We found that this normalization step yielded comparable fractions of fused Jurkat-hXBc2 per well and proved stable in further experiments. For detailed description of image analysis parameters and analysis sequence, see Supplemental Figure S1A-d. any of the three parameters described above by itself would not have been sufficient for discrimination between fused and nonfused cells in automated image analysis, but the combination of all parameters proved to be reliable and reproducible.
96-Well assay format
in 96-well format, nine nonoverlapping images per well were acquired, collecting 1500 to 3500 objects per compound concentration. analysis of large object counts provided good data confidence intervals for assay development and quality control. aMD 3100 served as a reference compound to calibrate assay conditions. one of the main objectives during development of this assay was to minimize reaction time to limit possible off-target effects. time course experiments indicated a cell combination time of 4 h as appropriate for quantitative image analysis (Supplemental Figure S4) and repeatedly provided fractions of fused Jurkat-hXBc2 of at least 0.7. Figure 2c provides numbers of cells or objects determined as described above for all three categories (free, attached, and fused) in the presence of increasing aMD 3100 concentrations. each data point represents the mean and standard deviation of the mean of nine images. in Figure 2d , fused Jurkat objects calculated by the algorithm were normalized to the sum of all cells per image, and data were fit to a four-parameter logistic sigmoidal dose response. in the experiment shown, the ec 50 value for aMD 3100 generated by analysis of fused cell fraction was 18 nM. Means of nine images with standard deviation of the means are presented. Multiple repeats of the fusion assay (n = 11 in 24 months) in the 96-well format yielded a mean ec 50 value for aMD 3100 of 27 nM with a 95% confidence interval of 14 to 40 nM.
inhibition of cell-cell fusion serves as a mechanistic confirmation of antiviral activity resulting from antagonism of receptor-mediated viral entry. ec 50 values determined in this assay were slightly higher than published ec 50 antiviral values for aMD 3100 (e.g., 1-6 nM 14 ) but within a twofold range of ec 50 values determined in our lab using the same U87MG-cXcr4 cell line (20 nM; data not shown). it also has been reported that bicyclams similar to aMD 3100 show slightly higher ec 50 in syncytia formation assays than in antiviral assays. 15 We concluded that this assay might be specific and sensitive to identify or confirm small-molecule inhibition of cXcr4-mediated virus entry.
384-Well assay format
to increase throughput, we sought to transfer the protocol to a 384-well format. strict automated cell processing during assay execution proved essential to ensure even cell distribution and a minimal number of 200 cells per image.
validation experiments were performed to assess assay performance in the 384-well format. several 384-well plates were subjected to identical assay conditions, and the fraction of fused cells in a single image per well was determined (Fig. 3A) . First, Jurkat-hXBc2 cells induced for envelope expression were transferred onto U87MG-cXcr4, and fusion was quantified immediately or after a 4-h incubation at 37 °c. at time 0 h, the mean fraction of fused cells was less than 0.01 with a standard deviation of 0.005. after a 4-h incubation, the mean fraction of fused Jurkat cells was 0.9 with a standard deviation of 0.03. We repeatedly observed an increase of fraction fused from 0.7 to 0.8 in the 96-well format to 0.9 in the 384-well format. We assume this was due to different cell distribution behavior in the 384-well format and the capture of a single image ignoring free cells that accumulated along the well wall.
Jurkat-hXBc2 cells without induction of envelope expression were used to establish background fusion events and to define assay limits. lack of hiv envelope expression was verified by surface staining and flow cytometry analysis (data not shown). lack of envelope expression yielded a mean fraction of fused Jurkat cells of 0.17 with a standard deviation of 0.05. We considered this value to be possibly caused by close association of Jurkat cells with target U87MG-cXcr4 cells causing spurious grouping of attached cells into the fused category. the fraction of attached Jurkat cell objects was 0.24, likely reflecting the movement of Jurkat cells toward U87MG-cXcr4 observed during assay development. nevertheless, Z′ values of 0.68 for this cell-cell fusion assay protocol in the 384-well format indicated a sufficient window for accurate and specific assessment of antifusion compound activity. Figure 3B shows response curves of multiple serial dilutions of aMD 3100 and two compounds (sch) from the schering-plough compound collection in 384-well plates. in three independent experiments, aMD 3100 showed ec 50 values of 34, 31, and 21 nM with overlapping 95% confidence intervals for the three values (left graph). For each concentration, quadruplicates were prepared, and one image per reaction was acquired. the four images were combined, resulting in 700 to 800 valid cell objects that were used to calculate the fraction of fused Jurkat cells. For each response curve, means of fractionfused Jurkat objects of four serial dilutions (repeats) with standard deviations were plotted.
two compounds of the schering-plough library that had shown antiviral activity (middle and right graph) mediated by cXcr4 were tested in duplicates. the two test compounds, a and B, revealed potencies in line with their potencies in antiviral assays (not shown).
additional data demonstrating assay performance in 384-well plates and further information regarding assay development can be found in Supplemental Figures S2 and S3.
Paradigm for confirmatory screening
We characterized the antifusion activity of preselected compounds in 384-well plates. We included the fusion inhibitor Krh-1636 at the concentrations 5, 0.5, and 0.05 µM as a positive control. 16 Using U87MG-cXcr4 in our hiv infectious assay, Krh-1636 had shown an antiviral activity of 1 µM ec 50 .
in a representative screening experiment, 93 structurally related compounds were tested at 25, 2.5, and 0.25 µM in quadruplicate. images containing at least 200 cells were analyzed, lower cell numbers were flagged as outliers (potential cytotoxicity; Fig. 4 , red data point), and reactions were scheduled for repeat. results of one representative plate are presented in Figure 4 .
the mean fraction of fused Jurkat-hXBc2 of 30 DMso control wells (0.835 with a standard deviation of 0.06) was used to calculate the threshold for decision making (indicated as a dotted line in Fig. 4) . compounds lowering the fraction fused to <0.726 (mean -2 sD) were considered "active" (Fig.  4) at the tested concentration. compounds inhibiting fusion at low concentrations only were assumed to affect cXcr4 receptor presentation. confirming its relatively low antiviral activity, four replicates of Krh-163 showed antifusion activity at 5 µM but only partial activity at 0.5 µM (Fig. 4, compound 20) . in this experiment, 9 of 93 tested compounds showed activity for at least three replicates at two concentrations. three of those compounds were confirmed as cXcr4-specific inhibitors with micromolar potency in infection assays using cXcr4-specific virus isolates (data not shown).
We developed an image-based cXcr4-specific cell fusion assay for identification or characterization of cXcr4 coreceptor antagonists. the selected combination of cells and assay conditions provided reproducible results. the combination of two cell fusion partners for a short time period (4 h) leading to measurable fusion activity may allow identification of molecules that most likely specifically inhibit interaction of hiv gp120 with the host cXcr4 coreceptor. the frequency of hits derived from off-target effects (e.g., compound-caused impairment of cell growth, reporter expression variations) might be reduced. if required, receptor surface presentation also can be monitored as well as cytotoxicity represented by morphology changes of the adherent cells.
Because of a large variety of live-cell dyes available and simple image analysis sequences, the assay can be transferred to any imaging platform available. in addition to being costeffective, this assay measured compound potency with high confidence in results. automated cell handling, compound treatment, data acquisition, and analysis made the assay amenable for testing large numbers of compounds.
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